Adam H. Roberts
EfpA is required for re-growth of Mycobacterium tuberculosis following isoniazid exposure
Roberts, Adam H.; Moon, Christopher W.; Faulkner, Valwynne; Kendall, Sharon L.; Waddell, Simon; Bacon, Joanna
Authors
Christopher W. Moon
Valwynne Faulkner
Sharon L. Kendall
Simon Waddell
Joanna Bacon
Abstract
Efflux of antibiotics is a survival strategy in bacteria. Mycobacterium tuberculosis has approximately sixty efflux pumps, but little is known about the role of each pump, or which moieties that they efflux. The putative efflux pump, EfpA, is a member of the major facilitator superfamily that has been shown to be essential by saturation transposon mutagenesis studies. It has been implicated in the efflux of the frontline drug isoniazid (INH) in M. tuberculosis. This is supported by evidence from transcriptional profiling that efpA is induced in response to INH exposure. However, its role in physiology and adaptation of M. tuberculosis to antibiotics, have yet to be determined. Here, we describe the repression of efpA using CRISPR interference and the direct effect of this on the ability of M. tuberculosis to survive exposure to INH over a 45-day time-course. We determined that wild-type levels of efpA were required for the recovery of M. tuberculosis cultures following INH exposure and that, after 45-days of INH exposure, no viable colonies were recoverable from efpA-repressed M. tuberculosis cultures. We postulate that EfpA is required for the recovery of M. tuberculosis following INH-exposure and that EfpA may have a role in the development of resistance, during treatment and contributes to relapse in patients.
Citation
Roberts, A. H., Moon, C. W., Faulkner, V., Kendall, S. L., Waddell, S., & Bacon, J. (in press). EfpA is required for re-growth of Mycobacterium tuberculosis following isoniazid exposure. Antimicrobial Agents and Chemotherapy, https://doi.org/10.1128/aac.00261-24
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 2, 2024 |
Online Publication Date | Jul 22, 2024 |
Deposit Date | Aug 6, 2024 |
Publicly Available Date | Aug 6, 2024 |
Journal | Antimicrobial Agents and Chemotherapy |
Print ISSN | 0066-4804 |
Electronic ISSN | 1098-6596 |
Publisher | American Society for Microbiology |
Peer Reviewed | Not Peer Reviewed |
DOI | https://doi.org/10.1128/aac.00261-24 |
Files
EfpA Is Required For Re-growth Of Mycobacterium Tuberculosis following Isoniazid Exposure
(2.1 Mb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Version
VoR
You might also like
Nitric oxide induces the distinct invisibility phenotype of Mycobacterium tuberculosis
(2024)
Journal Article
Galleria mellonella as an infection model for the virulent Mycobacterium tuberculosis H37Rv
(2022)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search